Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology

NCT02220556 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
360
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut Curie